UMIN ID: C000000431
Registered date:20/01/2014
The effectiveness of a Vitamin K2 analog on the recurrence of HCC after curative therapy
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | patients with HCC after curative treatment |
| Date of first enrollment | 2006/07/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | oral administration of Vitamin K2 analog without administration of Vitamin K2 analog |
Outcome(s)
| Primary Outcome | cumulative tumor recurrence rate |
|---|---|
| Secondary Outcome | survival |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (a)A planned case of postoperative interferon therapy after curative treatment of HCC (b) other malignancies (c)Vitamin K allergy (d)receiving warfarin or aspirin (e)ruptured HCC (d)Operation-related death (e)HCC reccurence detected via CT within 3 or 4 weeks (f)judged to be inadequate case of this clinical test for other reasons by doctors |
Related Information
| Primary Sponsor | National Hospital Organization Iwakuni Clinical Center |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshitaka Takuma |
| Address | 2-5-1 Kuroiso-cho, Iwakuni, Yamaguchi, Japan Japan |
| Telephone | 0827-32-7121 |
| takuma@enjoy.ne.jp | |
| Affiliation | National Hospital Organization Iwakuni Clinical Center Internal Medicine |
| scientific contact | |
| Name | Yoshitaka Takuma |
| Address | 2-5-1 Kuroiso-cho, Iwakuni, Yamaguchi, Japan Japan |
| Telephone | 0827-31-7121 |
| Affiliation | National Hospital Organization Iwakuni Clinical Center Internal Medicine |